Suven Pharmaceuticals Limited (NSE:SUVENPHAR)
1,226.45
+15.25 (1.26%)
Feb 21, 2025, 3:30 PM IST
Suven Pharmaceuticals Market Cap
Suven Pharmaceuticals has a market cap or net worth of 312.21 billion as of February 21, 2025. Its market cap has increased by 97.42% in one year.
Market Cap
312.21B
Enterprise Value
306.55B
Revenue
10.48B
Ranking
n/a
PE Ratio
112.18
Stock Price
1,226.45
Market Cap Chart
Since March 9, 2020, Suven Pharmaceuticals's market cap has increased from 33.71M to 312.21B, an increase of 926,205.27%. That is a compound annual growth rate of 530.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 312.21B | 7.70% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4,005.21B |
Divi's Laboratories | 1,528.32B |
Cipla | 1,195.03B |
Mankind Pharma | 968.92B |
Apollo Hospitals Enterprise | 918.92B |
Zydus Lifesciences | 890.87B |
Aurobindo Pharma | 647.68B |
Alkem Laboratories | 550.15B |